|
TMED2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79180000003942E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77645999999143E-05 |
| Normal-vs-Stage2 |
4.163500E-03 |
| Normal-vs-Stage3 |
3.120200E-03 |
| Normal-vs-Stage4 |
8.429900E-04 |
| Stage1-vs-Stage2 |
7.192400E-01 |
| Stage1-vs-Stage3 |
9.526000E-01 |
| Stage1-vs-Stage4 |
6.291200E-01 |
| Stage2-vs-Stage3 |
7.483000E-01 |
| Stage2-vs-Stage4 |
9.637600E-01 |
| Stage3-vs-Stage4 |
6.772800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64020000026355E-07 |
| Normal-vs-AfricanAmerican |
4.403200E-01 |
| Normal-vs-Asian |
4.849400E-01 |
| Caucasian-vs-AfricanAmerican |
3.15329999889258E-08 |
| Caucasian-vs-Asian |
4.019200E-01 |
| AfricanAmerican-vs-Asian |
2.998000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.75430000000287E-05 |
| Normal-vs-Female |
4.25280000004857E-06 |
| Male-vs-Female |
5.004600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.733800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.165740E-04 |
| Normal-vs-Age(61-80Yrs) |
1.77459999994856E-06 |
| Normal-vs-Age(81-100Yrs) |
1.668190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.061400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.252400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.231000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.687400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.199000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.778400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.685210E-01 |
| Normal-vs-Grade 2 |
3.08389999981173E-07 |
| Normal-vs-Grade 3 |
1.661090E-03 |
| Normal-vs-Grade 4 |
8.180900E-03 |
| Grade 1-vs-Grade 2 |
5.716000E-02 |
| Grade 1-vs-Grade 3 |
6.172600E-01 |
| Grade 1-vs-Grade 4 |
4.155800E-01 |
| Grade 2-vs-Grade 3 |
2.812400E-02 |
| Grade 2-vs-Grade 4 |
3.256200E-01 |
| Grade 3-vs-Grade 4 |
5.780800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.04909999979419E-07 |
| Normal-vs-ccB subtype |
1.66584999999886E-05 |
| ccA subtype-vs-ccB subtype |
5.870600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84959999996559E-06 |
| Normal-vs-N1 |
6.367800E-02 |
| N0-vs-N1 |
4.614400E-01 |
|
|
